EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy

Wenhua Qiao, Peng Dong, Hui Chen, Jianmin Zhang

Cells · 29.11.2024 · 13 (23) · 1976

DOI: 10.3390/cells13231976 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 29.11.2024. Verfasst von Wenhua Qiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory for T Cell and Immunotherapy, State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Immunology, Ins…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Induced Pluripotent Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Initiative for Innovative Medicine, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system capable of killing virus-infected cells and/or cancer cells. The commonly used NK cells for therapeutic applications include primary NK cells and immortalized NK cell lines. However, primary NK cell therapy faces limitations due to its restricted proliferation capacity and challenges in stable storage. Meanwhile, the immortalized NK-92 cell line requires irradiation prior to infusion, which reduces its cytotoxic activity, providing a ready-made alternative and overcoming these bottlenecks. Recent improvements in differentiation protocols for iPSC-derived NK cells have facilitated the clinical production of iPSC-NK cells. Moreover, iPSC-NK cells can be genetically modified to enhance tumor targeting and improve the expansion and persistence of iPSC-NK cells, thereby achieving more robust antitumor efficacy. This paper focuses on the differentiation-protocols efforts of iPSC-derived NK cells and the latest progress in iPSC-NK cell therapy. Additionally, we discuss the current challenges faced by iPSC-NK cells and provide an outlook on future applications and developments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalInduced Pluripotent Stem CellsCell DifferentiationHumansCell- and Tissue-Based TherapyAnimals

Stichwörter der Autor:innen

NK cellscancer immunotherapygene editingiPSC (induced pluripotent stem cell)

Autor:innen und Institutionen

  • CAMS Key Laboratory for T Cell and Immunotherapy, State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences…
  • Changzhou Xitaihu Institute for Frontier Technology of Cell Therapy, Changzhou 213000, China.

Förderung

  • CAMS Initiative for Innovative Medicine
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Beijing Municipal Commission of Science and Technology Fund for Innovative Drugs
  • Changzhou Science and Technology Program

Zitieren

APA

Qiao, W., Dong, P., Chen, H., & Zhang, J. (2024). Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy. Cells, 13(23), 1976. https://doi.org/10.3390/cells13231976

Vancouver

Qiao W, Dong P, Chen H, Zhang J. Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy. Cells. 2024;13(23):1976. doi:10.3390/cells13231976

BibTeX
@article{Qiao2024,
  author = {Qiao, Wenhua and Dong, Peng and Chen, Hui and Zhang, Jianmin},
  title = {Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {23},
  pages = {1976},
  doi = {10.3390/cells13231976}
}
Kostenlos starten →